Ana Gonzalez-Angulo

Ana Gonzalez-Angulo

UNVERIFIED PROFILE

Are you Ana Gonzalez-Angulo?   Register this Author

Register author
Ana Gonzalez-Angulo

Ana Gonzalez-Angulo

Publications by authors named "Ana Gonzalez-Angulo"

Are you Ana Gonzalez-Angulo?   Register this Author

100Publications

2798Reads

29Profile Views

Dynamic clonal remodelling in breast cancer metastases is associated with subtype conversion.

Eur J Cancer 2019 Oct 4;120:54-64. Epub 2019 Sep 4.

GEICAM (Grupo GEICAM de Investigación en Cáncer de Mama), Madrid, Spain; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Spain; IMIM Hospital del Mar Medical Research Institute; Barcelona, Spain; Medical Oncology Department Hospital del Mar, Barcelona, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.07.003DOI Listing
October 2019

Cooperative Effect of Oncogenic and in an HGF-Dominant Environment in Breast Cancer.

Mol Cancer Ther 2019 02 5;18(2):399-412. Epub 2018 Dec 5.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-18-0710DOI Listing
February 2019

Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer.

Breast Cancer Res 2017 Aug 15;19(1):93. Epub 2017 Aug 15.

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-017-0878-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557476PMC
August 2017

Impact of clinical trial on survival outcomes.

Breast Cancer Res Treat 2016 Sep 16;159(2):273-81. Epub 2016 Aug 16.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3942-5DOI Listing
September 2016

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

J Clin Oncol 2016 Apr 8;34(10):1134-50. Epub 2016 Feb 8.

Lyndsay N. Harris, Case Western Reserve University, Cleveland, OH; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria, VA; Lisa M. McShane, National Cancer Institute, Bethesda, MD; Fabrice Andre, Institute Gustave Roussy, Paris, France; Deborah E. Collyar, Patient Advocates in Research; Elizabeth H. Hammond, University of Utah and Intermountain Health Care, Salt Lake City, UT; Ana M. Gonzalez-Angulo and Robert C. Bast, The University of Texas MD Anderson Cancer Center, Houston; Robert G.Mennel, Baylor University Medical Center and Texas Oncology PA, Dallas, TX; Nicole M. Kuderer, University of Washington Medical Center, Seattle, WA; Minetta C. Liu, Mayo Clinic College of Medicine, Rochester, MN; and Catherine Van Poznak and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2016/02/05/JCO.2015.65
Web Search
http://www.instituteforquality.org/sites/instituteforquality
Web Search
http://www.instituteforquality.org/sites/instituteforquality
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2015.65.2289
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.65.2289DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933134PMC
April 2016

Effect of 21-Gene RT-PCR Assay on Adjuvant Therapy and Outcomes in Patients With Stage I Breast Cancer.

Clin Breast Cancer 2015 Dec 18;15(6):458-66. Epub 2015 Jun 18.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2015.06.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644681PMC
December 2015

Antiepileptic drug use improves overall survival in breast cancer patients with brain metastases in the setting of whole brain radiotherapy.

Radiother Oncol 2015 Nov 16;117(2):308-14. Epub 2015 Oct 16.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2015.10.009DOI Listing
November 2015

Phase II Randomized Study of Ixabepilone Versus Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2-Negative Breast Cancer.

Clin Breast Cancer 2015 Oct 24;15(5):325-31. Epub 2015 Mar 24.

Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2015.03.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568133PMC
October 2015

Recurrence and survival among breast cancer patients achieving a pathological complete response to neoadjuvant chemotherapy.

Breast Cancer Res Treat 2015 Sep 14;153(2):417-23. Epub 2015 Aug 14.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1444, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s10549-015-3533
Web Search
http://link.springer.com/10.1007/s10549-015-3533-x
Publisher Site
http://dx.doi.org/10.1007/s10549-015-3533-xDOI Listing
September 2015

Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

J Clin Oncol 2015 Aug 20;33(24):2695-704. Epub 2015 Jul 20.

Catherine Van Poznak and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Mark R. Somerfield, American Society of Clinical Oncology, Alexandria, VA; Robert C. Bast, Ana M. Gonzalez-Angulo, and William F. Symmans, University of Texas MD Anderson Cancer Center, Houston; Robert G. Mennel, Texas Oncology, Dallas, TX; Massimo Cristofanilli, Thomas Jefferson University-Kimmel Cancer Center, Philadelphia, PA; Matthew P. Goetz and Minetta C. Liu, Mayo Clinic, Rochester, MN; David G. Hicks, University of Rochester Medical Center, Rochester, NY; Elizabeth G. Hill, Medical University of South Carolina, Hollings Cancer Center, Charleston, SC; Wanda Lucas, Georgetown University, Washington, DC; Ingrid A. Mayer, Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN; and Lyndsay N. Harris, Seidman Cancer Center, Case Western Reserve University, Cleveland, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.61.1459DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478102PMC
August 2015

Breast cancer subtype and baseline characteristics from diabetic breast cancer patients are not different from nondiabetics.

Breast J 2014 Jul-Aug;20(4):434-6. Epub 2014 May 26.

Escuela de Medicina y Ciencias de la Salud del Tecnológico de Monterrey, Monterrey, Nuevo León, México; Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico, Distrito Federal, Mexico.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.12294DOI Listing
July 2015

Outcomes After Multidisciplinary Treatment of Inflammatory Breast Cancer in the Era of Neoadjuvant HER2-directed Therapy.

Am J Clin Oncol 2015 Jun;38(3):242-7

Departments of *Radiation Oncology †Breast Medical Oncology §Surgical Oncology ∥Pathology ¶Diagnostic Radiology ‡Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e3182937921DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880388PMC
June 2015

Phase II study of gefitinib in patients with advanced salivary gland cancers.

Head Neck 2015 May 30;37(5):644-9. Epub 2015 Mar 30.

Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas; Hematology/Medical Oncology Division, Northeast Ohio Medical University, Medina, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.23647DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669372PMC
May 2015

Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?

Oncotarget 2015 May;6(15):12890-908

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536987PMC
http://dx.doi.org/10.18632/oncotarget.3849DOI Listing
May 2015

Receptor status change from primary to residual breast cancer after neoadjuvant chemotherapy and analysis of survival outcomes.

Clin Breast Cancer 2015 Apr 2;15(2):153-60. Epub 2014 Oct 2.

Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Department of Systems Biology, The University of Texas M.D. Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2014.09.006DOI Listing
April 2015

SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancer.

J Natl Cancer Inst 2015 Mar 16;107(3). Epub 2015 Feb 16.

Departments of Breast Medical Oncology (AMGA, SL, SMT), Systems Biology (AMGA, GBM), Biostatistics (HC, YL, K-AD), Experimental Therapeutics (KSC), Investigational Cancer Therapeutics (AA, ET, SPP, VV-B, FMB), Pathology (AAS) and Surgical Oncology (FMB), The University of Texas MD Anderson Cancer Center, Houston, TX; Division of Hematology-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA (IK, EPW); Division of Hematology-Oncology, University of California, San Diego, CA (RK); Cancer Therapy Evaluation Program, NIH/National Cancer Institute, Rockville, MD (LAD).

View Article

Download full-text PDF

Source
https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnc
Publisher Site
http://dx.doi.org/10.1093/jnci/dju493DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342675PMC
March 2015

Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studies.

J Natl Cancer Inst 2014 Dec 8;107(2). Epub 2014 Dec 8.

Department of Oncology (MPG, MMA, JNI), Department of Health Sciences Research (VJS, KRK), and Department of Molecular Pharmacology and Experimental Therapeutics (MPG, SLS, MK, MMA), Mayo Clinic, Rochester, MN; Department of Genetics, University of North Carolina, Chapel Hill, NC (GOS, CMP); Center for Personalized Therapeutics, University of Chicago, Chicago, IL (YN, NJC, MJR); Foundation Medicine Inc., Cambridge, MA (JXS, PJS, VAM, JSR, RY); Novartis Pharmaceuticals Corporation, East Hanover, NJ (DC); Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, NY (JSR); Division of Hematology/Oncology, Vanderbilt University, Nashville, TN (HG); Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX (AMGA, OB); Department Breast Cancer Susceptibility and Pharmacogenomics, Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, University Tuebingen, German Cancer Consortium (DKTK) and German Cancer Research (DKTK), Heidelberg, Germany (HB).Current affiliation of H. Gomez: Departamento de Medicina Oncologica, Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju401DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565524PMC
December 2014

cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast Cancer.

J Cancer 2014 15;5(9):745-53. Epub 2014 Oct 15.

1. Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA ; 3. Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/jca.9696DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216798PMC
November 2014

Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancer.

Oncotarget 2014 Oct;5(19):9049-64

Department of Breast Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX. Systems Biology, The University of Texas, MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253418PMC
http://dx.doi.org/10.18632/oncotarget.2022DOI Listing
October 2014

Reverse-phase protein array for prediction of patients at low risk of developing bone metastasis from breast cancer.

Oncologist 2014 Sep 12;19(9):909-14. Epub 2014 Aug 12.

Departments of Breast Medical Oncology, Bioinformatics and Computational Biology, and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Breast Surgical Oncology, St. Luke's International Hospital, Tokyo, Japan; Department of Surgery, Division of Breast Surgical Oncology, The Showa University School of Medicine, Tokyo, Japan

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0099DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153464PMC
September 2014

Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline.

J Clin Oncol 2014 Jul 5;32(19):2078-99. Epub 2014 May 5.

Sharon H. Giordano and Ana M. Gonzalez-Angulo, University of Texas MD Anderson Cancer Center, Houston; Debra A. Patt, Texas Oncology, Austin, TX; Sarah Temin, American Society of Clinical Oncology, Alexandria, VA; Jeffrey J. Kirshner, Hematology/Oncology Associates of Central New York, East Syracuse; Sarat Chandarlapaty and Shanu Modi, Memorial Sloan Kettering Cancer Center; Francisco J. Esteva, New York University Cancer Institute, New York, NY; Jennie R. Crews, PeaceHealth St Joseph Cancer Center, Bellingham, WA; Nancy E. Davidson, University of Pittsburgh Cancer Institute and University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA; Ian Krop, Nancy U. Lin, and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Jennifer Levinson, Ponte Vedra Beach; Edith A. Perez, Mayo Clinic, Jacksonville; Naren Ramakrishna, University of Florida Health Cancer Center at Orlando Health, Orlando, FL; and Jane Perlmutter, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.0948DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076031PMC
July 2014

Recommendations on disease management for patients with advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: American Society of Clinical Oncology clinical practice guideline.

J Clin Oncol 2014 Jul 5;32(19):2100-8. Epub 2014 May 5.

Naren Ramakrishna, University of Florida Health Cancer Center at Orlando Health, Orlando; Edith A. Perez, Mayo Clinic, Jacksonville; Jennifer Levinson, Ponte Vedra Beach, FL; Sarah Temin, American Society of Clinical Oncology, Alexandria, VA; Sarat Chandarlapaty and Shanu Modi, Memorial Sloan Kettering Cancer Center; Francisco J. Esteva, New York University Cancer Institute, New York; Jeffrey J. Kirshner, Hematology/Oncology Associates of Central New York, East Syracuse, NY; Jennie R. Crews, PeaceHealth St Joseph Cancer Center, Bellingham, WA; Nancy E. Davidson, University of Pittsburgh Cancer Institute and University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA; Sharon H. Giordano and Ana M. Gonzalez-Angulo, University of Texas MD Anderson Cancer Center, Houston; Debra A. Patt, Texas Oncology, Austin, TX; Ian Krop, Eric P. Winter, and Nancy U. Lin, Dana-Farber Cancer Institute, Boston, MA; and Jane Perlmutter, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/32/19/2100.full.pdf
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2013.54.0955
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.54.0955DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366342PMC
July 2014

Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study.

J Clin Oncol 2014 Jul 2;32(20):2142-50. Epub 2014 Jun 2.

Ines Vaz-Luis, Melissa E. Hughes, Harold J. Burstein, Jane C. Weeks, Eric P. Winer, and Nancy U. Lin, Dana-Farber Cancer Institute; Beverly Moy, Massachusetts General Hospital, Boston, MA; Ines Vaz-Luis, Instituto de Medicina Molecular, Lisbon, Portugal; Rebecca A. Ottesen and Rizvan Mamet, City of Hope, Duarte; Hope S. Rugo, University of California, San Francisco, San Francisco, CA; Stephen B. Edge, Roswell Park Cancer Institute, Buffalo, NY; Stephen B. Edge, Baptist Cancer Center, Memphis, TN; and Ana M. Gonzalez-Angulo and Richard L. Theriault, University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.1608DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076026PMC
July 2014

EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer.

J Exp Clin Cancer Res 2014 Jul 23;33:58. Epub 2014 Jul 23.

Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13046-014-0058-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431485PMC
July 2014

Concordance of genomic alterations between primary and recurrent breast cancer.

Mol Cancer Ther 2014 May 7;13(5):1382-9. Epub 2014 Mar 7.

Authors' Affiliations: Departments of Investigational Cancer Therapeutics, Surgical Oncology, Bioinformatics and Computational Biology, Pathology, Systems Biology, and Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Foundation Medicine, Cambridge, Massachusetts; Albany Medical College, Albany, New York; Fundacion para la Investigacion; Departments of Hematology-Oncology and Pathology, Hospital Clinico Universitario de Valencia; and INCLIVA Biomedical Research Institute, Valencia, Spain.

View Article

Download full-text PDF

Source
http://mct.aacrjournals.org/cgi/doi/10.1158/1535-7163.MCT-13
Publisher Site
http://dx.doi.org/10.1158/1535-7163.MCT-13-0482DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348062PMC
May 2014

Implications of functional proteomics in breast cancer.

Oncologist 2014 Apr 24;19(4):328-35. Epub 2014 Mar 24.

Division of Cancer Medicine and Departments of Breast Medical Oncology and Systems Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2013-0437DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983827PMC
April 2014

HER2 testing: current status and future directions.

Cancer Treat Rev 2014 Mar 11;40(2):276-84. Epub 2013 Sep 11.

Mayo Clinic, 4500 San Pablo Rd., Jacksonville, FL 32224, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2013.09.001DOI Listing
March 2014

Advances and future directions in the targeting of HER2-positive breast cancer: implications for the future.

Curr Treat Options Oncol 2014 Mar;15(1):41-54

Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030-4009, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11864-013-0262-4
Publisher Site
http://dx.doi.org/10.1007/s11864-013-0262-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933950PMC
March 2014

Differences in gene and protein expression and the effects of race/ethnicity on breast cancer subtypes.

Cancer Epidemiol Biomarkers Prev 2014 Feb 2;23(2):316-23. Epub 2013 Dec 2.

Authors' Affiliations: Departments of Breast Medical Oncology, Biostatistics, Pathology, Systems Biology, and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Division of Hematology-Oncology, Yale University, New Haven, Connecticut.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-13-0929DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946290PMC
February 2014

Biomarker discordance pre and post neoadjuvant chemotherapy in breast cancer.

Cancer Biomark 2012-2013;12(6):241-50

Department of Medical Oncology, Dubai Hospital, Dubai, UAE.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/CBM-130315DOI Listing
January 2014

Breast Cancer Biomarkers: Utility in Clinical Practice.

Curr Breast Cancer Rep 2013 Dec;5(4)

Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA ; Department of Systems Biology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12609-013-0125-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882751PMC
December 2013

An evaluation of the impact of technical bias on the concordance rate between primary and recurrent tumors in breast cancer.

Breast 2013 Oct 25;22(5):974-9. Epub 2013 Jun 25.

Department of Oncology and Hematology, Research Institute INCLIVA, Hospital Clinico Universitario Valencia (HCUV), Avda Blasco Ibañez 17, 46010 Valencia, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2013.05.014DOI Listing
October 2013

Mesothelin expression and survival outcomes in triple receptor negative breast cancer.

Clin Breast Cancer 2013 Oct 27;13(5):378-84. Epub 2013 Jun 27.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2013.05.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839051PMC
October 2013

Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes.

Clin Cancer Res 2013 Oct 15;19(19):5533-40. Epub 2013 Aug 15.

Authors' Affiliations: Morgan Welch Inflammatory Breast Cancer Research Program and Clinic; Departments of Breast Medical Oncology, Bioinformatics and Computational Biology, Pathology, and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Department of Biochemistry, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0799DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813597PMC
October 2013

Weekly nab-Rapamycin in patients with advanced nonhematologic malignancies: final results of a phase I trial.

Clin Cancer Res 2013 Oct;19(19):5474-84

Authors' Affiliations: Departments of Breast Medical Oncology and Systems Biology, Surgical Oncology, and Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas; Sarcoma Oncology Center, Santa Monica; Division of Hematology-Oncology, University of California, San Diego, California; and Celgene, Summit, New Jersey.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-3110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935482PMC
October 2013

Locoregional interaction of ixabepilone (ixempra) after breast cancer radiation.

Oncologist 2013 12;18(3):265-70. Epub 2013 Feb 12.

Department of Radiation Oncology, The University of TexasMDAnderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2012-0348DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607521PMC
September 2013

Two birds with one stone: octreotide treatment for acromegaly and breast cancer.

J Clin Oncol 2013 Aug 24;31(23):e398-400. Epub 2013 Jun 24.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1354, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.46.6383DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878051PMC
August 2013

Genotype in BRCA-associated breast cancers.

Breast J 2013 Jan-Feb;19(1):87-91. Epub 2012 Dec 10.

Departments of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.12056DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437798PMC
June 2013

Progress in the biological understanding and management of breast cancer-associated central nervous system metastases.

Oncologist 2013 Jun 5;18(6):675-84. Epub 2013 Jun 5.

Departments of Breast Medical Oncology and Systems Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2012-0438DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063393PMC
June 2013

Adjuvant systemic therapies in breast cancer.

Surg Clin North Am 2013 Apr 8;93(2):473-91. Epub 2013 Feb 8.

Division of Hematology/Oncology, Comprehensive Cancer Center, University of Michigan Health System, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.suc.2012.12.002DOI Listing
April 2013

Breast cancer and metastasis: on the way toward individualized therapy.

Cancer Genomics Proteomics 2012 Sep-Oct;9(5):297-310

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, U.S.A.

View Article

Download full-text PDF

Source
February 2013

Breast cancer in 2012: New drugs, new knowledge, new targets.

Nat Rev Clin Oncol 2013 Feb 8;10(2):75-6. Epub 2013 Jan 8.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2012.236DOI Listing
February 2013

High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patients.

Breast Cancer Res Treat 2013 Jan 4;137(1):319-27. Epub 2012 Dec 4.

Department of Surgical Oncology, Unit 1484, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-012-2354-4
Publisher Site
http://dx.doi.org/10.1007/s10549-012-2354-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556743PMC
January 2013

Everolimus in the treatment of hormone receptor-positive breast cancer.

Expert Opin Investig Drugs 2012 Dec 20;21(12):1835-43. Epub 2012 Sep 20.

The University of Texas, MD Anderson Cancer Center, Department of Breast Medical Oncology, 1155 Herman P Pressler, CPB5.3540, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2012.726218DOI Listing
December 2012

High ERK protein expression levels correlate with shorter survival in triple-negative breast cancer patients.

Oncologist 2012 14;17(6):766-74. Epub 2012 May 14.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2011-0377DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380875PMC
November 2012

Biomarkers of response to Akt inhibitor MK-2206 in breast cancer.

Clin Cancer Res 2012 Oct 29;18(20):5816-28. Epub 2012 Aug 29.

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-1141DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772348PMC
October 2012

Impact of body mass index on survival outcome among women with early stage triple-negative breast cancer.

Clin Breast Cancer 2012 Oct;12(5):364-72

Department of Medical Oncology, Dubai Hospital, United Arab Emirates.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2012.07.013DOI Listing
October 2012

Targeting the hepatocyte growth factor-cMET axis in cancer therapy.

J Clin Oncol 2012 Sep 6;30(26):3287-96. Epub 2012 Aug 6.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Box 432, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.40.3774DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434988PMC
September 2012

Role of HGF/MET axis in resistance of lung cancer to contemporary management.

Transl Lung Cancer Res 2012 Sep;1(3):179-93

The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.2012.09.04DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367559PMC
September 2012

Hormone receptor-positive breast cancer: the known and the unknown.

Oncology (Williston Park) 2012 Aug;26(8):700-1

Department of Medical Oncology, Dubai Hospital, United Arab Emirates.

View Article

Download full-text PDF

Source
August 2012

The importance of accuracy in HER2 testing.

Clin Adv Hematol Oncol 2012 Aug;10(8):529-31

Department of Breast Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
August 2012

A new hypothesis for the cancer mechanism.

Cancer Metastasis Rev 2012 Jun;31(1-2):247-68

Breast Medical Oncology Department, MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10555-011-9342-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350627PMC
June 2012

To biopsy or not to biopsy: is that the only question?

Oncologist 2012 20;17(2):151-3. Epub 2012 Jan 20.

Department of Medical Oncology, Dubai Hospital, P.O. Box 8179, Dubai, UAE.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2011-0432DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286159PMC
June 2012

The use of bevacizumab among women with metastatic breast cancer: a survey on clinical practice and the ongoing controversy.

Cancer 2012 Jun 5;118(11):2780-6. Epub 2011 Oct 5.

Department of Medical Oncology, Dubai Hospital, Dubai, United Arab Emirates.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.26579DOI Listing
June 2012

Metformin and hepatic carcinogenesis.

Cancer Prev Res (Phila) 2012 Apr 31;5(4):500-2. Epub 2012 Mar 31.

Lady Davis Research Institute and McGill University, Montreal, Quebec, 3999 Chemin Cote Sainte Catherine, Montreal Quebec H3T 1E2, Canada.

View Article

Download full-text PDF

Source
http://cancerpreventionresearch.aacrjournals.org/cgi/doi/10.
Publisher Site
http://dx.doi.org/10.1158/1940-6207.CAPR-12-0080DOI Listing
April 2012

Gene expression, molecular class changes, and pathway analysis after neoadjuvant systemic therapy for breast cancer.

Clin Cancer Res 2012 Feb 10;18(4):1109-19. Epub 2012 Jan 10.

Departments of Breast Medical Oncology, Systems Biology, Biostatistics, Surgical Oncology, and Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-2762DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3288822PMC
February 2012

Targeting the PI3K signaling pathway in cancer therapy.

Expert Opin Ther Targets 2012 Jan 12;16(1):121-30. Epub 2012 Jan 12.

The University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology and System Biology, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14728222.2011.644788DOI Listing
January 2012